Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 3
1998 4
1999 2
2000 2
2002 2
2004 1
2005 3
2006 4
2007 4
2008 1
2010 1
2011 4
2012 6
2013 3
2014 3
2015 1
2016 2
2017 1
2018 1
2019 1
2020 2
2021 5
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Callejas JL, Ortego Centeno N. Callejas JL, et al. Med Clin (Barc). 2021 Apr 9;156(7):361. doi: 10.1016/j.medcli.2020.08.015. Epub 2021 Jan 8. Med Clin (Barc). 2021. PMID: 33431181 English, Spanish. No abstract available.
The Effect of Body Fat Distribution on Systemic Sclerosis.
Villanueva-Martin G, Acosta-Herrera M, Kerick M, López-Isac E, Simeón CP, Callejas JL, Assassi S, Beretta L, SSc Group I, Asig ASIG, Allanore Y, Proudman SM, Nikpour M, Fonseca C, Denton CP, Radstake TRDJ, Mayes MD, Jiang X, Martin J, Bossini-Castillo L. Villanueva-Martin G, et al. Among authors: callejas jl. J Clin Med. 2022 Oct 12;11(20):6014. doi: 10.3390/jcm11206014. J Clin Med. 2022. PMID: 36294335 Free PMC article.
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis.
Kerick M, Acosta-Herrera M, Simeón-Aznar CP, Callejas JL, Assassi S; International SSc Group; Proudman SM, Nikpour M; Australian Scleroderma Interest Group (ASIG); PRECISESADS Clinical Consortium; Hunzelmann N, Moroncini G, de Vries-Bouwstra JK, Orozco G, Barton A, Herrick AL, Terao C, Allanore Y, Fonseca C, Alarcón-Riquelme ME, Radstake TRDJ, Beretta L, Denton CP, Mayes MD, Martin J. Kerick M, et al. Among authors: callejas jl. NPJ Genom Med. 2022 Oct 5;7(1):57. doi: 10.1038/s41525-022-00327-8. NPJ Genom Med. 2022. PMID: 36198672 Free PMC article.
Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients.
Calderón-Goercke M, Loricera J, Moriano C, Castañeda S, Narváez J, Aldasoro V, Maiz O, Melero R, Villa JI, Vela P, Romero-Yuste S, Callejas JL, de Miguel E, Galíndez-Agirregoikoa E, Sivera F, Fernández-López JC, Galisteo C, Ferraz-Amaro I, Sanchéz-Martín J, Sánchez-Bilbao L, González-Gay MA, Hernández JL, Blanco R; Tocilizumab in Giant Cell Arteritis Spanish Collaborative Group. Calderón-Goercke M, et al. Among authors: callejas jl. Clin Exp Rheumatol. 2023 Apr;41(4):829-836. doi: 10.55563/clinexprheumatol/oqs8u9. Epub 2022 Nov 2. Clin Exp Rheumatol. 2023. PMID: 36377586 Free article.
Clinical characterization and outcomes of 85 patients with neurosarcoidosis.
Ramos-Casals M, Pérez-Alvarez R, Kostov B, Gómez-de-la-Torre R, Feijoo-Massó C, Chara-Cervantes J, Pinilla B, González-García A, Garcia-Morillo JS, López-Dupla M, De-Escalante B, Rascón J, Perez-Guerrero P, Bonet M, Cruz-Caparrós G, Alguacil A, Callejas JL, Calvo E, Soler C, Robles A, de Miguel-Campo B, Oliva-Nacarino P, Estela-Herrero J, Pallarés L, Brito-Zerón P, Blanco Y; SarcoGEAS-SEMI Registry. Ramos-Casals M, et al. Among authors: callejas jl. Sci Rep. 2021 Jul 2;11(1):13735. doi: 10.1038/s41598-021-92967-6. Sci Rep. 2021. PMID: 34215779 Free PMC article.
Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients.
Loricera J, Castañeda S, Moriano C, Narváez J, Aldasoro V, Maiz O, Melero R, Villa I, Vela P, Romero-Yuste S, Callejas JL, de Miguel E, Galíndez-Agirregoikoa E, Sivera F, Fernández-López JC, Galisteo C, Ferraz-Amaro I, Sánchez-Martín J, Sánchez-Bilbao L, Calderón-Goercke M, Casado A, Hernández JL, González-Gay MA, Blanco R. Loricera J, et al. Among authors: callejas jl. Ther Adv Musculoskelet Dis. 2022 Jul 22;14:1759720X221113747. doi: 10.1177/1759720X221113747. eCollection 2022. Ther Adv Musculoskelet Dis. 2022. PMID: 35898567 Free PMC article.
Coexistence of immune-mediated diseases in sarcoidosis. Frequency and clinical significance in 1737 patients.
Brito-Zerón P, Pérez-Alvarez R, Feijoo-Massó C, Gracia-Tello B, González-García A, Gómez-de-la-Torre R, Alguacil A, López-Dupla M, Robles A, Garcia-Morillo S, Bonet M, Cruz-Caparrós G, Fonseca-Aizpuru E, Akasbi M, Callejas JL, de Miguel-Campo B, Pérez-de-Lis M, Ramos-Casals M; SarcoGEAS-SEMI Registry. Brito-Zerón P, et al. Among authors: callejas jl. Joint Bone Spine. 2021 Dec;88(6):105236. doi: 10.1016/j.jbspin.2021.105236. Epub 2021 Jun 8. Joint Bone Spine. 2021. PMID: 34116201 Free article.
Identification of Mechanisms by Which Genetic Susceptibility Loci Influence Systemic Sclerosis Risk Using Functional Genomics in Primary T Cells and Monocytes.
González-Serna D, Shi C, Kerick M, Hankinson J, Ding J, McGovern A, Tutino M, Villanueva-Martin G, Ortego-Centeno N, Callejas JL, Martin J, Orozco G. González-Serna D, et al. Among authors: callejas jl. Arthritis Rheumatol. 2023 Jun;75(6):1007-1020. doi: 10.1002/art.42396. Epub 2023 Apr 9. Arthritis Rheumatol. 2023. PMID: 36281738 Free PMC article.
55 results